[1] Cao G, Yang S, Cao J, et al. The role of oxidative stress in intervertebral disc degeneration[J]. Oxid Med Cell Longev, 2022,2022:2166817. DOI: 10.1155/2022/2166817.
[2] Liu W, Jin S, Huang M, et al. Duhuo jisheng decoction suppresses matrix degradation and apoptosis in human nucleus pulposus cells and ameliorates disc degeneration in a rat model[J]. J Ethnopharmacol, 2020,250:112494. DOI: 10.1016/j.jep.2019.112494.
[3] Tian Y, Chu X, Huang Q, et al. Astragaloside IV attenuates IL-1β-induced intervertebral disc degeneration through inhibition of the NF-κB pathway[J]. J Orthop Surg Res, 2022,17(1):545. DOI: 10.1186/s13018-022-03438-1.
[4] Wang Y, Che M, Xin J, et al. The role of IL-1β and TNF-α in intervertebral disc degeneration[J]. Biomed Pharmacother, 2020,131:110660. DOI: 10.1016/j.biopha. 2020.110660.
[5] Akeda K, Ohishi K, Masuda K, et al. Intradiscal injection of autologous platelet-rich plasma releasate to treat discogenic low back pain: a preliminary clinical trial[J]. Asian Spine J, 2017,11(3):380-389. DOI: 10.4184/asj.2017.11.3.380.
[6] Levi D, Horn S, Tyszko S, et al. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial[J]. Pain Med, 2016,17(6):1010-22. DOI: 10.1093/pm/pnv053.
[7] 袁晨曦.富血小板血浆通过TGF-β1延缓椎间盘退变的初步研究[D].苏州:苏州大学,2014. DOI:10.7666/d.D504852.
[8] Chen WH, Lo WC, Lee JJ, et al. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma[J]. J Cell Physiol, 2006,209(3):744-754. DOI: 10.1002/jcp.20765.
[9] Wang HQ, Yu XD, Liu ZH, et al. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3[J]. J Pathol, 2011,225(2):232-242. DOI: 10.1002/path.2931.
[10] Boise LH, Gottschalk AR, Quintáns J, et al. Bcl-2 and Bcl-2-related proteins in apoptosis regulation[J]. Curr Top Microbiol Immunol, 1995,200:107-121. DOI: 10.1007/978-3-642-79437-7_8.
[11] Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death[J]. Nat Rev Mol Cell Biol, 2008,9(1):47-59. DOI: 10.1038/nrm2308.
[12] 闫菁,胡江杉,胡霞,等. 针刀治疗对退变兔腰椎间盘组织中凋亡调控基因Bcl-2和Bax表达的影响[J]. 湖北中医药大学学报,2023,25(1):5-9. DOI:10.3969/j.issn.1008- 987x. 2023.01.01.
[13] 刘大锐,李报春,李怀东. 细胞凋亡核心基因Caspase家族的研究进展[J]. 中国医药导刊,2020,22(11):800-805. DOI:10.3969/j.issn.1009-0959.2020.11.014.
[14] Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis[J]. Cell Death Differ, 1999,6(2):99-104. DOI: 10.1038/sj.cdd.4400476.
[15] Rodrigues LMR, Oliveira LZ, Silva MBRD, et al. Inflammatory biomarkers in sera of patients with intervertebral disc degeneration[J]. Einstein (Sao Paulo), 2019,17(4):eAO4637. DOI: 10.31744/einstein_journal/2019AO4637.
[16] 李玲慧,王尚全,孙凯,等. 杜仲苷调控核糖体生成抑制髓核细胞损伤和细胞外基质降解的机制研究[J]. 中国中药杂志,2024,49(21):5713-5720. DOI:10.19540/j.cnki.cjcmm. 20240802.401.
[17] 李硕夫,刘宏哲,张嘉麟,等. 牛膝总皂苷对IL-1β诱导髓核细胞的凋亡及炎性损伤的影响[J]. 湖南中医药大学学报,2023,43(9):1591-1597. DOI:10.3969/j.issn.1674- 070X. 2023.09.007.
[18] Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review[J]. EFORT Open Rev,2021,6(4):225-235. DOI: 10.1302/2058-5241.6.200017.
[19] 孙力,石辉. 富血小板血浆治疗膝关节炎的研究进展[J]. 国际医药卫生导报,2024,30(24):4106-4109. DOI:10.3760/cma.j.issn.1007-1245.2024.24.009.
[20] Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification[J]. Skin Appendage Disord, 2018,4(1):18-24. DOI: 10.1159/000477353.
[21] Navani A, Manchikanti L, Albers SL, et al. Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines[J]. Pain Physician, 2019,22(1S):S1-S74.
[22] Machado ES, Soares FP, Vianna de Abreu E, et al. Systematic review of platelet-rich plasma for low back pain[J]. Biomedicines, 2023,11(9):2404. DOI: 10.3390/biomedicines11092404.
[23] Navani A, Ambach M, Calodney A, et al. The safety and effectiveness of orthobiologic injections for discogenic chronic low back pain: a multicenter prospective, crossover, randomized controlled trial with 12 months follow-up[J]. Pain Physician, 2024,27(1):E65-E77.
[24] Nagae M, Ikeda T, Mikami Y, et al. Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres[J]. Tissue Eng, 2007,13(1):147-158. DOI: 10.1089/ten.2006.0042.
|